期刊文献+

1型和2型外壳蛋白构建的AAV载体携带HIV-1 gag诱导免疫反应的比较研究 被引量:3

Immune Responses Induced by Intramuscular Vaccination with rAAV2 and Pseudotyped rAAV1 Expressing HIV-1 gag
下载PDF
导出
摘要 比较两种血清型的腺病毒伴随病毒(Adeno-associated virus,AAV)载体携带HIV-1gag基因肌肉注射诱导小鼠免疫反应的特点。分别制备携带EGFP和HIV-1gag基因的重组AAV2/1(AAV1)和AAV2载体。小鼠肌肉注射rAAV1-EGFP和rAAV2-EGFP,观察注射局部EGFP的表达。将rAAV1-gag和rAAV2-gag分别以0、3周初免/加强方式肌肉注射免疫BALB/c小鼠以及新西兰白兔。ELISA法检测抗HIV-1 Gag P24蛋白的特异性抗体,细胞内细胞因子染色法检测Gag特异性的CTL反应。结果表明,rAAV1-EGFP在小鼠肌肉的表达强度显著高于rAAV2-EGFP;用Western blot法和间接免疫荧光法检测rAAV1-gag和rAAV2-gag体外转染的293细胞,均可检测到HIV-1 Gag蛋白的表达;在小鼠体内rAAV1-gag和rAAV2-gag组均可检测到特异性P24抗体,抗体滴度rAAV1-gag组显著高于rAAV2-gag组;而无论rAAV1-gag组还是rAAV2-gag组,特异性CTL反应均较低,与阴性对照组相比均无显著性差异;两种载体免疫兔子也都可检测到特异性P24抗体,同样地,rAAV1-gag组显著高于rAAV2-gag组。结论:携带HIV-1gag基因的rAAV1或rAAV2以肌肉注射方式免疫小鼠主要诱导特异Gag的体液免疫反应;且rAAV1可诱导很强的抗HIV-1 Gag特异性抗体,抗体水平显著高于rAAV2。 Immune responses against HIV-1 Gag resulting from recombinant adeno-associated virus serotype 2 (rAAV2-gag) and pseudotyped AAV1 (rAAVl-gag) by intramuscular vaccination were compared. At first, BALB/c mice were inoculated with 1 × 10^11 vg of AAV1-EGFP and AAV2-EGFP respectively. The expression of EGFP in muscle was detected under the long wavelenth UV lamp. Secondly, the codon-optimized HIV-1 gag gene was used to construct rAAV1-gag and rAAV2-gag. Gag expression was detected by indirect immunofluorescence assay and Western blot. BALB/c mice and rabbits were immunized with rAAV2-gag and rAAV1-gag in prime/boost scheme at week 0 and 3. The serum specific P24 IgG against HIV-1 Gag was detected by ELISA. Anti-Gag CTL response was detected by intracellular cytokine staining assay. The results showed that the level of EGFP expression was higher in BALB/c mice injected with rAAV1-EGFP than with rAAV2-EGFP. Gag expression was detectable in cultured cells infected with both rAAV2-gag and rAAV1-gag. Significantly higher level of anti-Gag IgG in serum was detectable in BALB/c mice and rabbits immunized with rAAVl-gag than that of animals immunized with rAAV2-gag. However, anti-Gag CTL responses in BALB/c mice were undetectable either with rAAV1-gag or with rAAV2-gag. The experiments suggested that rAAV1 and rAAV2 carrying HIV- 1 gag mainly elicited humoral rather than cellular immune response, and rAAVl-gag elicited significantly higher level of anti-Gag IgG than rAAV2-gag in both BALB/c mice and rabbits.
出处 《病毒学报》 CAS CSCD 北大核心 2007年第3期177-182,共6页 Chinese Journal of Virology
基金 中国综合性艾滋病研究项目(CIPRA U19AI51915-05) 国家973课题(2004CB518806)
关键词 HIV-1 GAG 腺病毒伴随病毒 免疫反应 HIV-1 gag adeno-associated virus immune response
  • 相关文献

参考文献2

二级参考文献14

  • 1萨姆布鲁克J 弗里奇EF.分子克隆实验指南(第二版)[M].北京:科学出版社,1992..
  • 2Liu D W,J Virol,2000年,74卷,6期,2888页
  • 3萨姆布鲁克 J,分子克隆实验指南(第2版),1992年
  • 4黄祯祥,医学簿学基础及实验技术,1990年,464页
  • 5VEMULAPALLI R,HE Y,CRAVERO S,SRIRANGANATHAN N,BOYLE SM,SCHURIG GG.OVEREXPRESSION OF PROTECTIVE ANTIGEN AS A NOVEL APPROACH TO ENHANCE VACCINE EFFICACY OF BRUCELLA ABORTUS STRAIN RB51[].Infection and Immunity.2000
  • 6Feltquate DM,Heaney S,Webster RG,et al.Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization[].Journal of Immunology.1997
  • 7ZHAN Y,YANG J,CHEERS C.CYTOKINES RESPONSE OF T-CELL SUBSETS FROM BRUCELLA ABORTUS-INFECTED MICE TO SOLUBLE BRUCELLA PROTEINS[].Infection and Immunity.1993
  • 8ONATE AA,CESPEDES S,CABRERA A,RIVERS R,GONZALEZ A,MUNOZ C,ET AL.A DNA VACCINE ENCODING CU, ZN SUPEROXIDE DISMUTASE OF BRUCELLA ABORTUS INDUCES PROTECTIVE IMMUNITY IN BALB/C MICE[].Infection and Immunity.2003
  • 9Kurar E,Splitter GA.Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response[].Vaccine.1997
  • 10TIBOR A,SAMAN E,DE WERGIFOSSE P,CLOECKAERT A,LIMET JN,LETESSON JJ.MOLECULAR CHARACTERIZATION, OCCURRENCE, AND IMMUNOGENICITY IN INFECTED SHEEP AND CATTLE OF TWO MINOR OUTER MEMBRANE PROTEINS OF BRUCELLA ABORTUS[].Infection and Immunity.1996

共引文献4

同被引文献20

  • 1余双庆,冯霞,陈国敏,龚非,周玲,曾毅.HIV-1B亚型gp120基因密码子优化前后免疫原性的比较[J].病毒学报,2004,20(3):214-217. 被引量:8
  • 2Ramshaw IA, Ramsay AJ. The prime-boost strategy:exciting prospects for improved vaccination. Immunol. Today, 2000,21 : 163-165.
  • 3Woodland DL. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol, 2004,25 : 98-104.
  • 4Buck CB, Pastrana DV, Lowy DR, et al. Efficient intracellular assembly of papillomaviral vectors. J Virol, 2004,78 : 751-757.
  • 5Woodberry T, Gardner J, EUiott SL, et al. Prime-boost vaccination strategies : CD8 T cell numbers, protection, and Thl bias. J Immunol. 2003,170 : 2599-2604.
  • 6Haglund K, Leiner 1, Kerksiek K, et al. Robust recall and long-term memory T cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.J Virol,2002,76:7506-7517.
  • 7Ready T. AIDSVAX flop leaves vaccine field unscathed [J]. Nat Med, 2003, 9(4): 376.
  • 8Wang S, Kennedy J S, West K, et al. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers[J]. Vaccine, 2008, 26 (31): 3947- 3957.
  • 9van der Meide P H, Groenestein R J, de Labie M C, et al. Enumeration of lymphokine secreting cells as a quantitative measure for cellular immune responses in Rhesus macaques[J]. J Med Primatol, 1995, Z4(4): 271-281.
  • 10Brockstedt D G, Podsakoff G M, Fong L, et al. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration[J]. Clinlmmunol, 1999, 92(1): 67-75.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部